Sequencing Of Agents And Combination Therapy In Castrate Resistant Prostate Cancer
AUAUniversity17 Okt 2019

Sequencing Of Agents And Combination Therapy In Castrate Resistant Prostate Cancer

Co-Host: Maxwell Meng, MD At the conclusion of these activities, participants will be able to: 1. Identify treatments for non-metastatic and metastatic CRPC and describe the proper order for their administration. 2. Manage nm and mCRPC with systemic agents by learning the proper candidates for treatment and be able to counsel patients on the pros and cons of therapy. 3. Review the newer generation antiandrogen agents and their use in nmCRPC and in mCRPC. CME Available: auau.auanet.org/node/26067 This educational series is supported by independent educational grants from: Amgen Astellas AstraZeneca Bristol-Myers Squibb Genomic Health Merck Pfizer, Inc. Sanofi Genzyme UroGen Pharma

Episoder(426)

Populært innen Fakta

fastlegen
dine-penger-pengeradet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
treningspodden
foreldreradet
rss-strid-de-norske-borgerkrigene
rss-sunn-okonomi
jakt-og-fiskepodden
sinnsyn
takk-og-lov-med-anine-kierulf
rss-kunsten-a-leve
gravid-uke-for-uke
merry-quizmas
hverdagspsyken
smart-forklart
rss-kull
fryktlos
hagespiren-podcast
rss-var-forste-kaffe
rss-mann-i-krise-med-sagen